Venetoclax combined with FLAG‐based chemotherapy induces an early and deep response in Mixed‐Phenotype‐Acute Leukemia

Corresponding Author

Olivier Spertini

Service and Central Laboratory of Hematology, Lausanne University Hospital (CHUV) and University of Lausanne, 1011, Lausanne, Switzerland

Correspondence

Amandine Segot, MD, MSc and Olivier Spertini, MD Service and Central Laboratory of Hematology Centre Hospitalier Universitaire Vaudois 1011 Lausanne, Switzerland Phone: +41 79 556

Email: amandine.segot@chuv.ch and olivier.spertini@chuv.ch

Search for more papers by this author

留言 (0)

沒有登入
gif